Alberto Molano was born in Bogotá, Colombia. He studied medicine at Universidad del Rosario and obtained a Ph.D. in Immunology from Weill Cornell Graduate School of Medical Sciences in New York. He conducted research and authored or co-authored twenty publications on molecular and cellular immunology, autoimmunity, immunology of aging and parasite immunology.
Increased levels of specific antibodies that can attack the host’s own tissues may be an early manifestation of systemic sclerosis (SSc) that can be detected years before clinical diagnosis. These autoantibodies may ... Read more
Systemic sclerosis (SSc) is not associated with clinically significant exocrine pancreatic dysfunction, a condition that can promote malnutrition in patients, researchers report. Of note, exocrine refers to the part of ... Read more
Certain clinical characteristics that researchers suggest could be potentially useful indicators of interstitial lung disease in systemic sclerosis (SSc) patients were recently identified in a study. Findings indicated that longer disease ... Read more
A new blood test measures autoantibodies called anti-vinculin, which have been found to be higher in scleroderma patients and have also been associated with gastrointestinal complications and pulmonary hypertension. The test, called sclero-smart, ... Read more
A recent study found that short-term progression rate of interstitial lung disease (ILD) in systemic sclerosis (SSc) is a better predictor of long-term survival than baseline ILD severity. ILD progression was ... Read more
Non-invasive, local treatment of digital ulcers with ozone for 20 days showed clinical effectiveness in systemic sclerosis patients, according to a new study. The study, “Non-invasive Oxygen-Ozone Therapy in Treating ... Read more
The presence of moderate or severe small joint contractures, finger ulcerations, and the severity of Raynaud’s phenomenon show the strongest association with impaired hand function in scleroderma patients, a study ... Read more